Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection

Ching–Lung Lai; Rosmawati Mohamed; Judy Lao; Hans Van Vlierberghe; Frank Anderson

doi:10.1053/gast.2002.37058

Home SearchPaper Details

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection

Ching–Lung Lai, Rosmawati Mohamed, Judy Lao, Hans Van Vlierberghe, Frank Anderson, Neal J. Thomas, Deborah DeHertogh

Elsevier BV (2002) • Volume 123, Issue 6, Pages 1831-1838

PDF Available

Quick Actions

Read Full Paper

Publication Info

DOI

10.1053/gast.2002.37058

Language

English

Topic

Hepatitis B Virus Studies

Keywords

Entecavir, Lamivudine, BDNA test, Medicine, HBeAg, Hepatitis B virus, Virology, Adefovir, Internal medicine, Gastroenterology, Hepatitis B, Seroconversion, Virus, Viral load, HBsAg

Published

November 26, 2002

Citations

300 citations

FWCI

20.55

External Resources

DOI Link OpenAlex

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection

Quick Actions

Publication Info

External Resources

Suggested Papers

Segment anything in medical images

Fire safety knowledge and awareness in high-rise residential buildings: an empirical study in China

Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial

Suggested Papers

Suggested Papers

Segment anything in medical images

Fire safety knowledge and awareness in high-rise residential buildings: an empirical study in China

Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial